Inquiry Basket
| Catalog | Product Name | CAS Number |
|---|---|---|
| BADC-00385 | perfluorophenyl 3-(2-(2-(2-(1,3-dioxoisoindolin-2-yloxy)ethoxy)ethoxy)ethoxy)propanoate | |
| Perfluorophenyl 3-(2-(2-(2-(1,3-dioxoisoindolin-2-yloxy)ethoxy)ethoxy)ethoxy)propanoate is a biomedical chemical. Serving as an exceptional drug delivery system, it facilitates precision-oriented transport of therapeutic agents to designated tissues or organs. | Inquiry | |
| BADC-00386 | 2,5-dioxopyrrolidin-1-yl 3-(2-(2-(2-(1,3-dioxoisoindolin-2-yloxy)ethoxy)ethoxy)ethoxy)propanoate | |
| 2,5-dioxopyrrolidin-1-yl 3-(2-(2-(2-(1,3-dioxoisoindolin-2-yloxy)ethoxy)ethoxy)ethoxy)propanoate is a small molecule active pharmaceutical ingredient that can be used as linking reagents for bioconjugation. | Inquiry | |
| BADC-00387 | perfluorophenyl 3-(2-(2-(1,3-dioxoisoindolin-2-yloxy)ethoxy)ethoxy)propanoate | |
| Perfluorophenyl 3-(2-(2-(1,3-dioxoisoindolin-2-yloxy)ethoxy)ethoxy)propanoate is a multi-faceted biomedical chemical. This compound has shown remarkable ability in developing drugs for a range of diseases, from malignancies to inflammation and even neurodegenerative diseases. Boasting an intricate molecular configuration, it exhibits unparalleled proficiency in targeted pharmacological delivery, ensuing heightened medication efficacy and improved bioaccessibility. | Inquiry | |
| BADC-00388 | 2,5-dioxopyrrolidin-1-yl 3-(2-(2-(1,3-dioxoisoindolin-2-yloxy)ethoxy)ethoxy)propanoate | |
| Kaempferol 3-(2-(2-(1,3-dioxoisoindolin-2-yloxy)ethoxy)ethoxy)propanoate is a naturally occurring flavonoid compound that exhibits remarkable potential in biomedical research and development. Its multifaceted properties and chemical composition make it a promising candidate for various therapeutic applications. By precisely targeting specific receptors or pathways implicated in numerous diseases, it holds the key to unlocking novel treatment approaches | Inquiry | |
| BADC-00389 | 2-(4-formylbenzamido)ethyl nitrate | 141534-26-1 |
| 2-(4-formylbenzamido)ethyl nitrate is a multifaceted biomedical compound. This compound has shown remarkable ability to prevent the proliferation of specific malignant cells and has been widely recognized for its anti-tumor properties. In addition, its potent antibacterial efficacy against specific bacterial strains has attracted widespread scientific interest. | Inquiry | |
| BADC-00390 | Ald-Ph-PEG4-acid | 1309460-27-2 |
| CHO-Ph-CONH-PEG4-acid is a small PEG reagent with a benzaldehyde moiety and a terminal carboxylic acid group. The benzaldehyde group is reactive with hydrazide and aminooxy moiety. The terminal carboxylic acid can undergo reactions with primary amines in the presence of activators such as EDC or HATU to form a stable amide bond. | Inquiry | |
| BADC-00391 | Ald-Ph-PEG3-acid | 1007215-91-9 |
| Ald-Ph-PEG3-acid is an advanced biomedical compound that has become a key entity in contemporary drug delivery systems. Its multifaceted functions as a profound linker and spacer during drug conjugation have attracted considerable attention from the scientific community. This extraordinary compound has a carefully designed chemical structure that significantly facilitates drug delivery at specific sites within the human body. | Inquiry | |
| BADC-00392 | Ald-Ph-PEG2-acid | 1061569-06-9 |
| Ald-Ph-PEG2-acid is a cutting-edge biochemical that is a key component in the synthesis of highly specific drug delivery systems. Its inherent properties as a linker effectively conjugate therapeutic drugs or imaging moieties to polyethylene glycol (PEG), thereby enhancing their solubility, stability, and pharmacokinetics. | Inquiry | |
| BADC-00393 | tert-butyl 1-(4-formylphenyl)-1-oxo-5,8,11-trioxa-2-azatridecan-13-oate | 1007215-94-2 |
| Tert-butyl 1-(4-formylphenyl)-1-oxo-5,8,11-trioxa-2-azatridecan-13-oate is a chemical compound prevalent in biomedicine. Its notable pharmacological attributes facilitate precise modulation of drug targets, affording effective control over a broad spectrum of maladies. Encouragingly, preliminary investigations indicate its considerable effectiveness in tackling drug-resistant malignancies and infectious pathology, thus inciting optimism for its prospective utilization in these domains. | Inquiry | |
| BADC-00394 | tert-butyl 1-(4-formylphenyl)-1-oxo-5,8,11,14,17,20,23,26,29,32,35-undecaoxa-2-azaheptatriacontan-37-ylcarbamate | 1245813-70-0 |
| tert-butyl 1-(4-formylphenyl)-1-oxo-5,8,11,14,17,20,23,26,29,32,35-undecaoxa-2-azaheptatriacontan-37-ylcarbamate is a non-cleavable 11-unit PEG ADC linker that can be used to synthesize antibo-conjugated drugs (ADCs). | Inquiry | |
| BADC-00395 | N-(35-amino-3,6,9,12,15,18,21,24,27,30,33-undecaoxapentatriacontyl)-4-formylbenzamide | 1337889-01-6 |
| CHO-Ph-CONH-PEG11-amine is a small molecule PEG linker with a benzaldehyde moiety and a terminal amine NH2 group. The benzaldehyde can undergo reactions with primary amine groups. The primary amine can react with carboxylic acids, activated NHS esters and other carbonyl compounds. The hydrophilic PEG linker increases the water solubility of the compound in aqueous solutions. | Inquiry | |
| BADC-00396 | Ald-PEG4-PFP | 1324007-10-4 |
| Ald-PEG4-PFP is a widely used chemical entity in the biomedical field, epitomizing its utility in drug delivery and target identification. Its composition exhibits a noteworthy polyethylene glycol derivative dominated by pentafluorophenyl (PFP) ester groups that binds efficiently to proteins and antibodies. This innovation significantly contributes to the advancement of groundbreaking treatments and diagnostics specifically targeting diseases such as cancer and autoimmune diseases. | Inquiry | |
| BADC-00397 | Ald-PEG4-NHS ester | 1353011-74-1 |
| Ald-PEG4-NHS ester is a non-cleavable 4-unit PEG linker that can be used to synthesize antibody-conjugated drugs (ADCs). | Inquiry | |
| BADC-00398 | 2,3,4,5,6-pentafluorophenyl 3-[2-(2-{2-[(4-formylphenyl)formamido]ethoxy}ethoxy)ethoxy]propanoate | |
| 2,3,4,5,6-pentafluorophenyl 3-[2-(2-{2-[(4-formylphenyl)formamido]ethoxy}ethoxy)ethoxy]propanoate is a remarkable medicinal chemical entity that is effective against a variety of shows great potential in diseases. It exerts profound effects on heterogeneous variants of tumors, particularly breast and lung cancer, by complexly inhibiting key proteins involved in malignant proliferation and spread. | Inquiry | |
| BADC-00399 | 2,5-dioxopyrrolidin-1-yl 3-[2-(2-{2-[(4-formylphenyl)formamido]ethoxy}ethoxy)ethoxy]propanoate | |
| 2,5-dioxopyrrolidin-1-yl 3-[2-(2-{2-[(4-formylphenyl)formamido]ethoxy}ethoxy)ethoxy]propanoate is a biomedical compound that has shown efficacy in fighting specific diseases . With its remarkable ability to block the proliferation of certain malignant cells by precisely targeting designated cell communication pathways, it represents great potential as an anticancer drug. | Inquiry | |
| BADC-00400 | perfluorophenyl 3-(2-(2-(4-formylbenzamido)ethoxy)ethoxy)propanoate | |
| perfluorophenyl 3-(2-(2-(4-formylbenzamido)ethoxy)ethoxy)propanoate is a highly complex and versatile biomedical compound. It is touted for its potential efficacy in fighting a variety of diseases and is a promising drug candidate. | Inquiry | |
| BADC-00991 | Tris[[2-(tert-butoxycarbonyl)ethoxy]methyl]methylamine | 175724-30-8 |
| Tris[[2-(tert-butoxycarbonyl)ethoxy]methyl]methylamine is a cleavable PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Amino-Tri-(t-butoxycarbonylethoxymethyl)-methane is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. | Inquiry | |
| BADC-00401 | Ald-Ph-PEG2-NHS | 1807521-07-8 |
| Ald-Ph-PEG2-NHS is a non-cleavable 2-unit PEG linker that can be used to synthesize antibody-conjugated drugs (ADCs). | Inquiry | |
| BADC-00402 | perfluorophenyl 3-(2-(4-formylbenzamido)ethoxy)propanoate | |
| perfluorophenyl 3-(2-(4-formylbenzamido)ethoxy)propanoate is a small molecule biomedical compound that has shown excellent ability to treat a variety of diseases. Its unparalleled properties enable targeted drug delivery and diagnostic modalities. Extensive research has revealed its great potential in combating neoplastic, autoimmune and infectious diseases. | Inquiry | |
| BADC-00403 | NHS-PEG12-azide | 1610796-02-5 |
| NHS-PEG12-azide is a vital tool in the biomedical industry. It serves as a linker for bioconjugation, allowing efficient attachment of azide groups to biomolecules. This product facilitates the development of targeted drug delivery systems, diagnostic probes, and bioimaging agents. It finds applications in treating various diseases such as cancer, cardiovascular disorders, and infectious diseases. | Inquiry |
